Patent Yard Sign in
Canadian application, no grantCanada

Drug conjugates and methods of designing the same

CA 2382202 A1 · Owner: Brenner, Sydney · Inventors: Brenner, Sydney; Stackhouse, Joseph; Millward, Steven W.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to drug conjugates and methods of their design. One embodiment of the invention is directed to a method of designing vector-linkerpharmacophore ("VLP") conjugates that is generally applicable to a wide variety of vectors, linkers, and pharmacophores. The invention also encompasses a method of improving the delivery of a pharmacophore to a patient, as well as a method of improving the therapeutic efficacy of a pharmacophore and a method of decreasing the toxicity of a pharmacophore. A method of increasing the concentration of a pharmacophore in a cell is further encompassed by the invention.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 28, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 28, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 28, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 28, 2000
GrantedNo grant recorded
Term endedAugust 28, 2020
Patent numberCA 2382202 A1
Classification (IPC)—

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedAug 28, 2000Term endedAug 28, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.